Drug Information Association Logo

DIA Announces 2011-2012 Board of Directors

Horsham, PA, USA — Jun 20, 2011

DIA today announced its 2011-2012 Board of Directors. The announcement came during DIA 2011 being held June 19-23 in Chicago, IL. The Board of Directors set the overall strategy for DIA activities.

Executive Committee:

  • Dr. Yves Juillet, DIA President, LEEM, France
  • Ling Su, DIA President-elect, Novartis Pharmaceuticals, China
  • Dr. Richard Day, DIA Immediate-past President
  • Minnie Baylor-Henry, DIA Treasurer, Johnson & Johnson Medical Devices & Diagnostics, USA


Michele Livesey, Livesey Consulting, USA

  • Dr. Sandra Milligan, Amgen, USA
  • Dr. Sandra L. Kweder, FDA, USA
  • Dr. Steve Caffé, Medimmune, USA
  • Truus Janse-de Hoog, Medicines Evaluation Board, The Netherlands
  • Dr. Thomas Kühler, GE Healthcare Bio-Sciences, Sweden
  • John A. Roberts, InfoLogix, USA
  • Dr. Per Spindler, University of Copenhagen, Denmark
  • Dr. Jean A Yager, BioPharm People, USA

Regional Advisory Council Chairs:

  • Larisa Nagra Singh, DIA Advisory Council of India, Voisin Consulting Life Sciences, India
  • Dr. Ning Xu, DIA Advisory Council of China, Covance Pharmaceutical R&D (Beijing)
  • Dr. Jennifer L. Riggins, DIA Advisory Council of North America, Eli Lilly and Company, US
  • Beat Widler, DIA Advisory Council of Europe, Clinical Quality and Risk Management Expert
  • Dr. Tatsuo Kurokawa, DIA Advisory Council of Japan, Keio University Faculty of Pharmacy

“Being an effective global community is a core component of DIA’s mission,” says Paul Pomerantz, DIA Worldwide Executive Director. “That’s why I want to personally recognize and thank each member of our Board of Directors comprised as it is of dedicated volunteers from every continent.”





ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. The dedicated efforts of DIA staff, members and speakers enable DIA to provide a comprehensive catalogue of conferences, workshops, training courses, scientific publications and educational materials. DIA is a global community representing thousands of stakeholders working together to bring safe and effective products to patients. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Penn., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit www.diahome.org.